Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

NCT02100514 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
746
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer